首页> 外文期刊>Talanta: The International Journal of Pure and Applied Analytical Chemistry >Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry
【24h】

Multi-residue method for trace level determination of pharmaceuticals in environmental samples using liquid chromatography coupled to triple quadrupole mass spectrometry

机译:液相色谱与三重四极杆质谱联用的多残留方法测定环境样品中的痕量药物

获取原文
获取原文并翻译 | 示例
       

摘要

A multi-residue method for the simultaneous determination of more than 90 pharmaceuticals in water samples was developed and validated. The developed method utilizes a single liquid chromatography-tandem mass spectrometry (LC-MS/MS) run after sample enrichment using solid-phase extraction (SPE). The pharmaceuticals included in this method were chosen based on their potency (effect/concentration ratio) and potential to bioaccumulate in fish. Because the selection was based on ecotoxicological criteria and not on ease of detection, the pharmaceuticals have a wide range of physico-chemical properties and represent 27 distinct classes. No method for surface, waste water or similar matrices was previously described for 52 of the 100 target analytes. Four chromatographic columns were tested to optimize the separation prior to detection by mass spectrometry (MS). The resulting method utilizes a Hypersil Gold aQ column. Three different water matrices were tested during method validation: Milli-Q water, surface water (river water from the Umea River) and effluent from the Umea waste water treatment plant (WWTP). Four of the selected pharmaceuticals exhibited poor method efficiency in all matrices. Amiodarone, Dihydroergotamine, Perphenazine and Terbutalin were omitted from the final analytical method. In addition, five compounds were excluded from the method for surface water (Atorvastatin, Chloropromazin, Dipyridamol, Furosemid and Ranitidin) and three other pharmaceuticals (Glibenclamid, Glimepirid and Meclozine) from waste water method respectively. Absolute recoveries were above 70 for Milli-Q water, surface water, and sewage effluent for most pharmaceuticals. The limits of quantification (LOQs) ranged from 0.05 to 50 ng L ~(-1) (median 5 ng L ~(-1)). The use of matrix-matched standards led to the elimination of ionization enhancement or suppression. The recoveries of the method for real matrices were in the range of 23-134 for surface water (only three compounds were outside of the range of 40-130) and in the range of 47-162 for waste water (five compounds were outside of the range of 40-130 at lower validated concentration).
机译:开发并验证了一种同时测定水样品中90多种药物的多残留方法。所开发的方法利用了使用固相萃取(SPE)富集样品后运行的单液相色谱-串联质谱(LC-MS / MS)。根据其效力(效果/浓度比)和在鱼类中生物富集的潜力来选择此方法中包括的药物。由于选择是基于生态毒理学标准,而不是基于易于检测,因此这些药物具有广泛的理化特性,代表了27种不同的类别。之前没有针对100种目标分析物中的52种方法描述过表面,废水或类似基质的方法。在通过质谱(MS)检测之前,测试了四个色谱柱以优化分离。所得方法利用了Hypersil Gold aQ色谱柱。在方法验证期间测试了三种不同的水基质:Milli-Q水,地表水(来自于默奥河的河流水)和来自于默奥废水处理厂(WWTP)的废水。所选药物中的四种在所有基质中均显示出较差的方法效率。最终分析方法中省略了胺碘酮,二氢麦角胺,奋乃静和特布他林。此外,从废水法中排除了地表水方法中的五种化合物(阿托伐他汀,氯promazin,双嘧达莫,呋塞米德和雷尼替丁)和其他三种药物(格列本克,格列美和甲氯嗪)。大多数药物的Milli-Q水,地表水和污水的绝对回收率均高于70。定量限(LOQ)为0.05至50 ng L〜(-1)(中位数为5 ng L〜(-1))。使用基质匹配的标准品可消除电离增强或抑制。对于地表水,实际基质方法的回收率在23-134范围内(只有三种化合物不在40-130范围内),在废水的回收率在47-162范围内(五种化合物不在水质范围内)。在较低的验证浓度下为40-130的范围)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号